Categories
Beyond

U.S. Fed Rate Cut Sparks Global Market Rally, Raises Inflation Questions

Global financial markets responded strongly to the U.S. Federal Reserve’s decision to cut interest rates by 25 basis points, a move that had been widely anticipated. The benchmark federal funds rate now stands in the range of 4.75% to 5.00%, marking the first reduction since the central bank began its tightening cycle in 2022.

Wall Street closed higher following the announcement, with the S&P 500 rising 1.2%, the Dow Jones Industrial Average gaining 0.9%, and the Nasdaq Composite adding 1.6%. Investors welcomed the cut as a signal that the Fed is prioritizing growth amid signs of cooling inflation and a slowdown in the U.S. labor market.

Asian and European markets followed suit. Japan’s Nikkei 225 advanced 1.4%, Hong Kong’s Hang Seng climbed 1.7%, and South Korea’s Kospi gained 1.2%. In Europe, the FTSE 100 rose 0.8%, while Germany’s DAX index gained 1.1%. Emerging markets also saw an uptick in investor sentiment, with India’s Sensex and Brazil’s Bovespa posting notable gains.

Currency markets reflected the shift in U.S. monetary policy, with the dollar weakening against most major currencies. The euro appreciated to $1.11, while the yen strengthened to 143 per dollar. The softer dollar supported gains in commodity markets, particularly gold, which rose to $2,420 per ounce, and oil, with Brent crude climbing above $86 per barrel.

While the Fed’s move was widely anticipated, analysts have raised concerns about its potential inflationary effects. A rate cut reduces borrowing costs, spurs consumer spending, and can boost investment, but it also carries the risk of reigniting price pressures. U.S. inflation has eased from its peak above 9% in 2022 to 3.2% in August, but remains above the Fed’s 2% target.

Federal Reserve Chair Jerome Powell, in his press conference, emphasized that the cut was a “calibrated adjustment” rather than the beginning of a large easing cycle. He noted that while inflation is trending downward, risks remain, particularly from energy markets and supply chain disruptions. Powell added that the Fed would continue to monitor incoming data closely and adjust policy as necessary.

The decision also carries significant implications for global central banks. Some, like the European Central Bank and the Bank of England, are weighing their own rate paths amid mixed signals on inflation and growth. Emerging market central banks, many of which raised rates aggressively in recent years, may find additional space to cut as U.S. monetary tightening recedes.

In the bond market, yields on U.S. Treasuries fell sharply, with the 10-year yield dropping to 3.85% from 4.05% prior to the announcement. Lower yields reflect increased demand for government debt and signal expectations of looser financial conditions ahead.

Also Read: Gameskraft CFO in ₹270 Cr Fraud; 120 Jobs Cut

Categories
Corporate

Roche to Acquire 89bio for Up to $3.5 Billion

Roche has entered into a definitive merger agreement to acquire clinical-stage biopharmaceutical company 89bio, Inc. in a deal valued at up to $3.5 billion.

Under the terms of the agreement, an affiliate of Roche will commence a tender offer to purchase all outstanding shares of 89bio at $14.50 per share in cash at closing, representing an aggregate equity value of about $2.4 billion.

In addition, 89bio stockholders will receive a non-tradeable contingent value right (CVR) that could deliver up to an additional $6.00 per share upon achievement of specified regulatory or commercial milestones, bringing the total potential transaction value to roughly $3.5 billion.

The acquisition gives Roche ownership of pegozafermin, an investigational FGF21 analogue that 89bio is developing as a treatment for moderate to severe metabolic dysfunction-associated steatohepatitis (MASH).

Pegozafermin is currently in late-stage clinical development and is viewed by both companies as a potential therapy for a disease with substantial unmet medical need. Roche said the asset complements its cardiovascular, renal and metabolic disease portfolio and offers optionality for future combination development.

Financial markets reacted strongly to the announcement. Shares of 89bio surged sharply on the news, rising more than 80 percent in early trading as the market priced in Roche’s offer and the potential milestone payments.

Roche’s own shares showed mixed moves as investors assessed the strategic implications. Reports noted the cash portion of the deal values 89bio at about $2.4 billion on closing, with the CVR accounting for the upside to $3.5 billion.

Roche said the acquisition will be integrated into its pharmaceuticals division and that it expects the deal to strengthen its presence in therapies for liver and cardiometabolic diseases.

The companies indicated that Roche will work to advance pegozafermin through the remaining clinical programme and to prepare for potential regulatory submissions, while exploring how the candidate might fit alongside Roche’s broader development and commercial capabilities.

The press release noted that specific development and regulatory plans will be outlined as the integration proceeds.

The transaction remains subject to customary closing conditions, including expiration or termination of the tender offer, regulatory clearances, and other conditions specified in the merger agreement.

Roche will commence the tender offer promptly, and if the offer is successful, the companies will complete the merger and effect the payment at closing, with the CVR mechanism determining any contingent payments tied to future milestones. The timing of the closing will depend on procedural and regulatory steps.

The acquisition comes amid heightened competition among major pharmaceutical companies to build capabilities in obesity-related and metabolic disease areas, where FGF21 analogues and other novel mechanisms are attracting investment.

Pegozafermin’s late-stage status and the potential size of the MASH patient population underpin Roche’s willingness to offer a significant upfront cash consideration plus milestone-linked upside.

At the same time, regulatory review outcomes and commercial performance will determine the long-term value of the asset.

Roche has framed the acquisition as a way to enhance its cardiovascular, renal and metabolic (CVRM) portfolio by adding a late-stage therapeutic candidate for liver disease and bolstering options for future combination approaches in metabolic conditions.

89bio’s board and management have recommended the transaction to their shareholders, and 89bio will provide customary disclosures and updates as the tender offer proceeds.

Categories
Corporate

SEBI Clears Adani of Hindenburg Allegations; Group Stocks Jump

India’s securities regulator has dismissed key allegations made by U.S. short-seller Hindenburg Research against the Adani group, triggering a sharp rally in the conglomerate’s listed stocks and ending more than two years of market and political turmoil. In two separate orders issued this week, the Securities and Exchange Board of India (SEBI) concluded that the transactions flagged by Hindenburg did not amount to market manipulation, related-party breaches or disclosure failures that would attract punitive action.

The Hindenburg report, published in January 2023, accused the Adani empire of opaque related-party dealings, use of tax havens and stock manipulation — allegations that precipitated a near-$150 billion decline in the group’s market value and a prolonged period of regulatory and investor scrutiny. SEBI’s recent findings, which the Adani group said vindicate its position, mark the most consequential development to date in the saga and are likely to reshape investor sentiment toward the group.

Gautam Adani welcomed SEBI’s orders. In public posts and statements he described the regulator’s probe as exhaustive, calling the outcome a “resounding victory” and saying the Hindenburg report had been “baseless” and damaging to investors. The company reiterated that it has always sought to comply with disclosure norms and corporate governance standards.

Markets reacted quickly to the regulator’s decision. Shares across the Adani family of companies surged in early trading: Adani Total Gas and other utilities led the gains, while flagship Adani Enterprises and power units posted sizeable rises. Adani Power was among the biggest movers, trading sharply higher on the news, and analysts noted the verdict removed a major overhang that had weighed on group valuations since 2023.

As of the latest market quotes, Adani Enterprises was trading around ₹2,402 per share, while Adani Power’s intraday levels were substantially higher following the SEBI announcement, with market data providers showing prices in the mid-600s range as traders pushed the stock up on renewed buying interest. These price moves reflect broad repricing after regulators effectively rejected the most serious manipulation claims. Investors should note that real-time quotes vary across exchanges and data vendors.

Although SEBI’s orders clear the group on the charges reviewed in these particular filings, some market participants reminded investors that multiple probes and legal battles related to the episode have been pursued in different forums over time. International inquiries and other civil litigation that originated after the Hindenburg report remain separate matters and may continue to attract scrutiny. Observers also warned that while the headline risk has receded, valuation and governance debates are likely to persist as analysts reassess earnings traction and capital-intensive expansion plans.

Regulators’ conclusions are likely to have political as well as financial implications. The Hindenburg episode had become a flashpoint in public debates about corporate transparency, the effectiveness of oversight, and the relationship between business conglomerates and the state. SEBI’s findings will be seized upon by both critics and defenders of the group in arguments over market integrity and investor protection.

For now, the immediate effect is clear: investors rewarded Adani stocks after SEBI’s verdict, and the group has framed the outcome as vindication. Market watchers will next focus on whether the regained confidence translates into sustained capital inflows, how earnings and debt metrics evolve over coming quarters, and whether any remaining regulatory or legal threads emerge from domestic or foreign authorities.

Explainer: What SEBI Investigated and Found

SEBI’s probe focused on several core allegations:

  • Use of offshore entities: Hindenburg had alleged that Adani family associates and shell companies in tax havens were used to pump up stock prices. SEBI examined beneficial ownership records, fund flows, and trading data and concluded that the transactions did not breach disclosure or related-party rules.
  • Stock manipulation: The short-seller claimed that concentrated holdings by opaque foreign investors distorted the market. SEBI’s analysis of trade patterns, shareholding data, and market impact did not establish manipulation under Indian securities law.
  • Disclosure lapses: Hindenburg pointed to alleged under-reporting of related-party dealings. SEBI found that the filings made by Adani companies were materially compliant and that any gaps did not constitute willful concealment or fraud.

The regulator issued two separate but related orders to address these areas. While clearing the group of wrongdoing on these counts, SEBI indicated that it would continue to strengthen disclosure and surveillance frameworks to avoid similar controversies in the future.

Also Read: Hyundai India Approves ₹31,000 Monthly Pay Hike for Employees

Categories
Corporate

Oil India Sets ₹1.3 Trillion Capex Target by 2030

Oil India Ltd (OIL), the state-owned upstream company, has announced that it plans to spend a cumulative ₹1.3 trillion by 2030 on a wide range of projects spanning exploration, production, refinery expansion, and green energy. The figure was shared by Chairman and Managing Director Ranjit Rath during the company’s 66th Annual General Meeting, and reflects the most ambitious spending programme in the company’s history.

The capex plan will be spread across upstream exploration, downstream infrastructure, and alternative energy initiatives. On the upstream side, Oil India is prioritising deep-water exploration and enhanced recovery projects to raise crude oil and natural gas production. Downstream, the Numaligarh Refinery expansion project in Assam is a key focus, scheduled for completion by December this year. Beyond hydrocarbons, the company has earmarked significant funds for green hydrogen, biofuels, and compressed biogas (CBG), underscoring its intent to gradually diversify into cleaner fuels.

Oil India has indicated that in the current fiscal year alone, it will invest about ₹17,000 crore. This is almost double the ₹8,500 crore it spent the previous year, signalling a sharp escalation in the pace of its investments. Over the longer term, the ₹1.3 trillion outlay is expected to be divided across three primary buckets: roughly half for upstream oil and gas exploration and production, about 30 percent for downstream and refinery projects, and the remainder for renewable and green energy initiatives.

Despite global geopolitical disruptions, particularly surrounding its overseas assets in Russia, Oil India maintains that its operations remain unaffected. The company has recovered over 91 percent of its original $1 billion investment in the Vankorneft and Taas Yuryakh projects through dividends. While about $330 million remains blocked in Russian banks, Oil India expects to retrieve the full amount by FY2026-27. Drilling and production activities in these fields continue without interruption.

Overseas ventures are playing an increasingly important role in the company’s portfolio. Oil India is also involved in the Mozambique LNG project, where construction is expected to resume by late 2025. Once operational, the facility will add to India’s long-term gas security. In FY2024-25, overseas assets in Russia, Venezuela and Mozambique contributed over two million metric tonnes of oil equivalent, bolstering total company output.

Operationally, Oil India recorded its highest ever combined oil and natural gas production in FY2024-25, reaching 6.71 million metric tonnes of oil equivalent. Crude oil output has steadily increased over the past three years, from around 3.01 million metric tonnes in FY2021-22 to 3.46 million metric tonnes in FY2024-25. Natural gas production also hit new highs, reinforcing the company’s ability to meet its growth targets.

A notable portion of the ₹1.3 trillion capex will be directed toward green energy. Industry estimates suggest that nearly ₹25,000–30,000 crore will go into hydrogen projects alone, as Oil India explores pilot plants in Assam and Rajasthan. The company is also working with technology partners on electrolyser manufacturing and hydrogen blending in pipelines. Another ₹15,000–20,000 crore is expected to be channelled into biofuels and compressed biogas, including projects under the government’s Sustainable Alternative Towards Affordable Transportation (SATAT) scheme. Additionally, around ₹10,000 crore has been earmarked for solar and wind projects, with the company planning to add up to 2 GW of renewable power capacity by 2030.

The scale of the capex plan reflects Oil India’s twin priorities: consolidating its upstream strength while laying the groundwork for a transition to cleaner fuels. The refinery expansion at Numaligarh and progress on LNG assets abroad are expected to provide medium-term stability, while investments in hydrogen, biofuels and CBG are designed to prepare the company for a lower-carbon future.

If successfully executed, the ₹1.3 trillion programme will significantly expand Oil India’s production base, diversify its energy portfolio, and strengthen India’s energy security in the coming decade.

Categories
Technology

Nvidia’s $5 Billion Bet on Intel: A Surprise Alliance That Shakes Up the Chip World

Nvidia stunned markets and the semiconductor industry on September 18, 2025, when it announced a strategic partnership with Intel that includes a $5 billion purchase of Intel common stock and a multi-year collaboration to co-develop chips for data centers and personal computers.

Nvidia said it will buy Intel shares at $23.28 apiece — a purchase that would give it roughly a 4 percent stake in the long-troubled chipmaker — and that the two companies will work on “multiple generations” of custom x86 data-center CPUs and new Intel x86 System-on-Chips (SoCs) that integrate Nvidia RTX graphics.

The deal represents an extraordinary rapprochement between the world’s most valuable chip designer and one of the industry’s oldest names.

Nvidia’s chief executive described the move as a strategic step to deepen its data-center and PC ecosystem, while Intel framed the agreement as a validation of its turnaround efforts and a way to accelerate its roadmap for advanced manufacturing and product co-development.

The companies said specifics of jointly developed products would be revealed in stages, but they emphasised that designs will span both server CPUs used in AI infrastructure and client chips for laptops and desktops that pair Intel compute with Nvidia RTX graphics.

Markets reacted immediately. Intel shares surged more than 25 percent as investors cheered the cash infusion and the signal of renewed commercial relevance; reports placed intraday gains in the range of roughly 24–33 percent depending on the exchange and time of trading. Nvidia’s stock also rose, though far more modestly, climbing roughly 3–4 percent as the market weighed the strategic merits of the tie-up.

Rival chipmakers such as AMD saw share weakness amid concerns that a closer Intel-Nvidia axis could reconfigure competitive dynamics in data-center and PC segments.

Why this matters beyond the immediate market rally is twofold. First, Nvidia gains a significant, long-term alignment with a major x86 CPU vendor at a time when its AI products increasingly rely on tight integration with processors and interconnects.

Second, Intel — which has struggled in recent years with manufacturing delays and competitive pressure — secures both a large capital boost and a marquee partner that could help drive customer interest in Intel-based platforms.

Analysts note, however, that the deal stops short of guaranteeing a major manufacturing contract for Intel; Nvidia continues to rely on external foundries like TSMC for much of its highest-end silicon production, and details about where and how the new chips will be manufactured were left deliberately vague.

Industry watchers flagged potential geopolitical and strategic implications.

The partnership could reshape supply-chain relationships, put pressure on Taiwan Semiconductor Manufacturing Company (TSMC) as a supplier to both rivals and partners, and prompt closer scrutiny from regulators given the centrality of chips to national economic and security strategies.

At the same time, some analysts cautioned that bringing two large engineering organisations into a long, complex co-development process carries execution risk: aligning roadmaps, achieving performance targets, and choosing manufacturing partners are all hard problems that could blunt the deal’s near-term commercial impact.

For customers and the broader tech ecosystem, the announcement promises new product architectures in which Intel CPUs and Nvidia GPUs are designed to work more tightly together, potentially simplifying procurement and performance tuning for AI workloads.

Whether the partnership delivers tangible advantages over existing combinations of Nvidia accelerators with ARM or AMD CPUs will depend on execution and on how the companies allocate production and engineering resources across competing priorities.

In short, Nvidia’s $5 billion investment is both a financial vote of confidence in Intel and a strategic opening of a new chapter in the chip industry.

The market’s euphoric response reflects that promise, but the long road from announcement to product — and from product to profitable market share — contains many technical, commercial and regulatory hurdles that both companies will now have to clear.

Also Read: Gameskraft CFO in ₹270 Cr Fraud; 120 Jobs Cut

Categories
Beyond

Union Finance Ministry Notifies Revised GST Rates

The Union Finance Ministry has announced new Central Goods and Services Tax (CGST) rates for goods, effective Monday, September 22, 2025. States are expected to follow suit and notify the corresponding State GST (SGST) rates on goods and services to ensure uniform implementation across the country. Under the GST framework, revenues are shared equally between the Centre and the states.

Starting September 22, GST will adopt a two-tier structure, with most goods and services falling under 5% or 18% tax rates. Ultra-luxury items will attract 40%, while tobacco and related products will remain in the 28% slab along with the applicable compensation cess. Currently, GST applies in four slabs—5%, 12%, 18%, and 28%—with additional cesses on luxury and sin goods.

With the reduction in rates, businesses are expected to pass on the benefits to consumers and ensure timely compliance. According to Rajat Mohan, Senior Partner at AMRG & Associates, the government’s clear notification provides much-needed guidance on the applicable rates for a wide range of goods. He noted that businesses now have the responsibility to update their systems, revise pricing, and implement the new rates effectively across their supply chains. He added that the reform’s success will largely depend on how transparently and efficiently industry responds to the revised tax structure.

Similarly, Saurabh Agarwal, Tax Partner at EY, highlighted that companies must align their ERP systems, pricing strategies, and supply chain operations with the updated GST rates. This alignment, he said, is crucial not only for smooth implementation but also to ensure that consumers actually benefit from the rationalized rates.

The GST Council, comprising representatives from both the Centre and the states, approved the rate reduction to ease the burden on consumers during its meeting on September 3, 2025. With the revised rates coming into effect next week, businesses nationwide are gearing up for a seamless transition to ensure compliance and proper benefit transfer to end consumers.

Also Read: Devastating Rains in Uttarakhand: 10 Missing in Chamoli, 2,500 Stranded in Mussoorie

Categories
Technology

Meta Launches Ray-Ban Smart Glasses with AI-Powered Display, Neural Wristband

Meta has launched its latest wearable innovation, the Ray-Ban Display smart glasses, aiming to redefine the future of personal computing. Unveiled at the company’s annual Connect 2025 event, the glasses feature an integrated augmented reality (AR) display and advanced artificial intelligence (AI) capabilities, paired with a new neural wristband controller. Priced at $799, the smart glasses are set to be released on September 30, 2025.

Integrated Display and Neural Wristband for Hands-Free Control

The Meta Ray-Ban Display glasses include a built-in AR display on the right lens, enabling users to access notifications, navigation directions, real-time translations, and other digital content seamlessly. The display is designed to minimize light leakage, ensuring privacy while viewing information. Powered by the Qualcomm Snapdragon AR1 Gen 1 processor, the glasses integrate smoothly with Meta’s suite of applications, allowing video calls, photo sharing, and AI-generated content directly on the device.

Accompanying the glasses is the Meta Neural Band, an electromyography (EMG) wristband that translates subtle muscle movements into commands. Users can control the glasses with simple gestures such as pinches, swipes, or wrist turns, without touching the device or using voice commands. The wristband boasts an 18-hour battery life, water resistance, and an intuitive hands-free interface, positioning the device as both practical and innovative.

The glasses also feature a 12-megapixel camera, five microphones, and dual off-ear speakers to support high-quality video and audio capture, live streaming, and immersive media consumption. A collapsible charging case extends battery life by up to 30 hours, ensuring usability throughout the day.

Strategic Vision and Market Potential

Meta’s launch of the Ray-Ban Display glasses marks a strategic push into the wearable AI market, combining fashion-forward design with cutting-edge technology. The company envisions the glasses as a new computing platform, potentially replacing some smartphone functionalities while offering a more immersive, AI-driven experience. Analysts note that success will depend not only on hardware innovation but also on the development of software and ecosystem integration that can fully leverage the AI capabilities.

This release is part of Meta’s broader vision to embed AI into everyday devices. The company is also developing its “Orion” smart glasses prototype, which promises even more advanced augmented reality experiences in the future. With the Ray-Ban Display glasses and the neural wristband, Meta aims to bring AI closer to everyday users, offering a glimpse into the next generation of personal technology and wearable computing.

By merging style with technology, Meta hopes to attract consumers seeking seamless digital integration in daily life. The glasses represent a significant step toward transforming how people interact with technology, emphasizing gesture-based control, real-time information access, and AI-driven functionality.

Categories
Corporate

Hyundai India Approves ₹31,000 Monthly Pay Hike for Employees

Chennai: In a deal being hailed as one of the most generous in India’s automobile sector, Hyundai Motor India Limited (HMIL) has inked a three‑year wage settlement with its workers’ union that includes a salary increase of ₹31,000 per month. The Long Term Settlement (LTS) covers the period from April 1, 2024, through March 31, 2027, and applies to nearly 1,981 employees in the technician and workmen cadre—which represents about 90 per cent of that category at the company’s Sriperumbudur plant.

Under the agreement with the United Union of Hyundai Employees (UUHE), the pay hike will be phased in over the three years in a ratio of 55 per cent in the first year, 25 per cent in the second, and 20 per cent in the final year. In addition to the salary boost, Hyundai has committed to enhanced welfare measures—comprehensive health coverage and wellness programmes—to improve employee well‑being.

Market Response and Implications

Investors welcomed the announcement. The company’s shares hit record highs following the wage pact, rising by around 2‑3 per cent as markets factored in strong labour relations and improved employee satisfaction. Analysts see this move as strengthening HMIL’s position in the Indian auto industry, underlining its reputation for maintaining a stable workforce and avoiding protracted labour disputes.

At a time when global supply chains and automotive firms are under pressure from rising input costs and shifting labour expectations, Hyundai India’s settlement could become a benchmark for peer companies. For employees, the deal brings relief and recognition; for the company, it may mean higher wage bills, but also potentially better productivity, morale, and lower attrition.

Hyundai’s move also aligns with increasing expectations among Indian industrial workers for more substantial compensation, especially given inflationary pressures and rising costs of living. If management elsewhere in the sector responds with similar wage revisions, India could see a new normal in labour costs. However, cost pressures for OEMs (original equipment manufacturers) and suppliers will likely increase, which may affect pricing, margins, and negotiations in the supply chain in the months ahead.

Categories
Corporate

Gujarat Fluorochemicals Promoter Offloads ₹460 Crore Stake, Trims Holding to 61.4%

New Delhi: Devansh Trademart LLP, one of the promoters of Gujarat Fluorochemicals (GFL), has sold a 1.18% stake in the company through an open market transaction valued at approximately ₹460.11 crore. The divestment, executed on September 17, 2025, involved the sale of 13 lakh equity shares at ₹3,539.30 per share on the National Stock Exchange.

Prior to the sale, Devansh Trademart held about 4.84% of the equity. The transaction reduces its shareholding to approximately 3.66%, while the combined promoter group’s stake in GFL drops from around 62.58% to about 61.40%. The buyers of the shares have not been identified in the public filings.

On the trading front, Gujarat Fluorochemicals’ stock saw a modest rise. Shares closed at roughly ₹3,699 per share on the NSE following the announcement.

What the Stake Sale Means

The sale marks a notable shift in promoter shareholding, a move that often attracts investor attention in companies with strong promoter-led control. While Devansh Trademart’s stake is still meaningful, the reduction underscores a possibility that promoter exits—or at least partial divestments—are becoming more frequent.

For investors, these kinds of large promoter sales can trigger mixed reactions. On one hand, there could be concern about why the promoter is selling—whether it’s for capital raising, debt repayment, or diversification of assets. On the other hand, if the company’s fundamentals remain intact, such sales might simply reflect financial strategy or compliance pressures.

GFL operates in speciality chemicals, refrigerants, fluoropolymers and industrial chemicals, and has been expanding into fluoropolymer capacities. Its product lines serve both domestic and international markets. For companies in such sectors, promoter holding changes are often scrutinised for signs of confidence in future prospects.

Market Outlook

Regulatory norms under the Securities and Exchange Board of India (SEBI) require disclosures of substantial ownership changes, and the reduction in stake by Devansh Trademart has been duly disclosed in exchange data.

In terms of risk, market participants will be watching for any further promoter sales, since attrition of promoter shareholding over time can impact perceptions of control and governance. Additionally, if the market interprets the sale as a signal of concern, the stock may come under pressure. But in this case, the share price moved only marginally—which suggests that investors may view the sale as a one-off rather than a signal of trouble.

Devansh Trademart’s sale of a 1.18% stake for about ₹460 crore in Gujarat Fluorochemicals is a significant promoter-divestment transaction. While it reduces both its own holding and the promoter group’s overall control, it doesn’t fundamentally alter the ownership structure. For shareholders, the key question will be whether this move was driven by strategy rather than necessity, and how GFL performs going forward in its chemicals and fluoropolymer businesses.

Also Read: Former Lodha Developers Director Arrested in ₹85 Crore Land-Fraud

Categories
Beyond

U.S. Fed Rate Cut Lifts Indian Markets as IT Stocks Lead the Rally

On September 17, 2025, the U.S. Federal Reserve lowered its benchmark interest rate by 25 basis points to a range of 4.00%–4.25 percent, marking its first cut of the year. The move, aimed at addressing signs of a slowing labour market and moderating economic growth, set off a positive reaction across global markets, with Indian equities among the biggest beneficiaries.

The rate cut was widely anticipated, but its confirmation still triggered a rally on Dalal Street. The Sensex gained over 300 points in early trade, while the Nifty 50 crossed the 25,400 mark. The Nifty IT index saw the sharpest gains, rising by nearly 1.7 percent, led by strong buying in Infosys, Wipro, LTIMindtree, and other technology heavyweights. Mid-cap and small-cap indices also firmed up, reflecting the broader bullish sentiment.

Market Implications for India

The Fed described the move as a “risk-management” measure, citing increased downside risks to employment alongside persistent inflationary pressures. It also hinted at the possibility of two more cuts before the year ends. For India, the immediate impact is likely to be in terms of improved foreign capital inflows. Lower yields in the United States make emerging markets like India relatively more attractive, particularly sectors such as IT and financial services that are closely tied to global capital cycles.

A softer dollar, which often follows a Fed rate cut, also eases pressure on the Indian rupee, curbs import-led inflation, and provides a boost to exporters. This dynamic not only strengthens investor confidence but also creates a more favourable environment for sectors that rely heavily on overseas markets. Banking and financial stocks are expected to benefit as well, since lower global borrowing costs improve liquidity and sentiment across the board.

However, analysts caution that the benefits could be temporary, as markets had largely priced in the 25 basis point cut ahead of the announcement. Structural challenges also remain. Indian IT companies, though buoyed by the prospect of greater U.S. spending, continue to grapple with subdued demand, delayed contracts, and rising cost pressures. Similarly, while the rupee stands to gain, volatility in global currencies cannot be ruled out if inflation surprises to the upside or if geopolitical risks intensify.

The Federal Reserve’s communication suggested a cautious path forward. While signalling its readiness for further easing, it maintained that inflation risks have not fully abated. This leaves investors with the possibility of future rate adjustments being more measured than aggressive. For Indian markets, the extent of gains will depend not only on global liquidity flows but also on domestic factors such as corporate earnings, inflation management, and fiscal policy moves in the run-up to the year’s end.

Looking ahead, the trajectory of U.S. monetary policy will remain a central driver for Indian equities. Should the Fed deliver additional cuts as indicated, it could reinforce positive momentum in emerging markets and spur further foreign inflows. At the same time, the Reserve Bank of India is unlikely to mirror the Fed immediately, given its own inflation management priorities. This divergence could influence currency movements and bond yields in the months ahead.

For now, the Fed’s decision has provided a clear tailwind for Indian investors, energising key sectors and lifting benchmark indices to fresh highs.

Yet the rally is tempered with caution.

Traders and policymakers alike recognize that while global liquidity is turning favourable, sustaining the momentum will require steady domestic growth, stronger consumption trends, and supportive reforms. In this delicate balance between global monetary policy and local fundamentals, India’s markets find themselves both buoyed by opportunity and tested by lingering risks.